Dimethyl fumarate for the treatment of plaque psoriasis

By  

PRESCRIBER, Vol. 29, Iss. 1, 2018-01 ,pp. : 37-38

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of open‐label ixekizumab treatment in Japanese patients with moderate‐to‐severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 6, 2015-06 ,pp. : 1148-1155

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies

By Prignano F.   Ricceri F.   Pescitelli L.   Buggiani G.   Troiano M.   Zanieri F.   Rossari S.   Lotti T.  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2311-2316

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab in the treatment of moderate‐to‐severe chronic plaque psoriasis in patients switching from other biologics

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 9, 2015-09 ,pp. : 1742-1749

John Wiley & Sons Inc

Access to resources Recommend Favorite

Infliximab biosimilar CT‐P13 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : e325-e326

John Wiley & Sons Inc

Access to resources Recommend Favorite